We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksProteome Share News (PRM)

Share Price Information for Proteome (PRM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.60
Bid: 3.20
Ask: 4.00
Change: -0.55 (-13.25%)
Spread: 0.80 (25.00%)
Open: 4.15
High: 0.00
Low: 0.00
Prev. Close: 4.15
PRM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Proteome Appoints Geoffrey Ellis As Finance Director, Loss Widens

Tue, 30th Sep 2014 09:41

LONDON (Alliance News) - Proteome Sciences PLC said Tuesday that has appointed Geoffrey Ellis as Finance Director, and posted a slightly widened pretax loss for the half-year to the end of June.

Ellis previously acted as chief financial officer of The Walt Disney Co's Network of Disney Channels in Europe, the Middle East and Africa, and managing director Disney Channel Scandinavia, Middle East and Emerging Markets.

Ellis succeeds James Malthouse, who is retiring after 20 years with the company.

Proteome posted a pretax loss of GBP2.1 million, widened from a loss of GBP1.9 million a year before, as revenue declined to GBP784,276 from GBP885,475, and administrative expenses rose slightly to GBP2.5 million from GBP2.3 million.

The company said following the growth in licensing, services and sales of its Tandem Mass Tag reagents in 2013, its core technologies had continued to strengthen in the first-half of 2014. Some contracts it was expecting were delayed, however, and the company said because of their size it is difficult to predict when they will come through.

Proteome said that whilst it is "difficult to be precise" over the timing of these revenue contributions, the scale and number of contracts in its order book is "growing steady and that performance is expected to continue in 2015."

Sales of Tandem Mass Tag reagent's rose 98% compared to the previous year. Proteome expects to see a more significant contribution from the products in the second-half, as well as continued improvement in its revenues from licences, sales and services.

Last Friday the company announced "excellent" results from in vitro toxicity tests for its two lead compounds to treat Alzheimer's disease, which it hopes will attract pharmaceutical companies to partner with Proteome on the treatments.

Shares in Proteome are trading down 8.0% at 35.18 pence Tuesday morning.

By Hana Stewart-Smith; hanassmith@alliancenews.com; @HanaSSAllNews

Copyright 2014 Alliance News Limited. All Rights Reserved.

More News
26 Apr 2024 11:18

Proteome wins GBP500,000 deal to supply mass spectrometry services

(Alliance News) - Proteome Sciences PLC on Friday said it won a contract from an unnamed US biopharmaceutical company to use Proteome's mass spectrometry services.

Read more
26 Apr 2024 10:40

AIM WINNERS & LOSERS: Proteome Sciences rises on GBP500,000 contract

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Friday.

Read more
26 Apr 2024 09:45

Proteome Sciences secures contract win with US biopharmaceutical firm

(Sharecast News) - Contract proteomics service Proteome Sciences has secured a contract win from a US biopharmaceutical company using the company's mass spectrometry services for the analysis of samples for an on-going clinical trial.

Read more
26 Apr 2024 09:14

LONDON MARKET OPEN: Thoma Bravo snaps up Darktrace for USD5 billion

(Alliance News) - Stock prices in London opened higher on Friday, as investors shook off nerves ahead of US inflation data this afternoon.

Read more
10 Apr 2024 11:26

Proteome Sciences shares drop as revenue plunges and swings to loss

(Alliance News) - Proteome Sciences PLC on Wednesday said it swung to a loss in 2023 on higher costs, and saw its revenue plunge on contract delays.

Read more
2 Jan 2024 14:44

Proteome launches San Diego lab operations

(Sharecast News) - Proteomics services provider Proteome Sciences announced the installation and start of operations at its new laboratory in San Diego, California, on Tuesday.

Read more
2 Jan 2024 10:52

IN BRIEF: Proteome Sciences says San Diego lab now fully operational

Proteome Sciences PLC - London-based protein-focused drug development services provider - Completes installation and setup of equipment in its new lab in San Diego, California. The lab is now fully operational. Back in May, Proteome had announced it was expanding its proteomics services to the US. Says that the lab is "well placed to serve demand from a growing number of US customers looking to outsource proteomics projects to underpin their drug development programmes".

Read more
1 Dec 2023 12:01

Proteome Sciences issues profit warning after project delays

(Sharecast News) - Proteome Sciences, the AIM-listed protein sequencing contract research organisation, has warned it will swing to a net loss this year with full-year sales lower than expected.

Read more
30 Nov 2023 11:04

AIM WINNERS & LOSERS: Totally slides again; Proteome warns on earnings

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday.

Read more
30 Nov 2023 09:42

Proteome Sciences shares drop as cuts annual revenue outlook

(Alliance News) - Proteome Sciences PLC shares plummeted on Thursday, after it cut its revenue outlook for 2023 amid delays to projects.

Read more
2 Oct 2023 10:17

Proteome Sciences sees shares surge on SysQuant service launch

(Alliance News) - Proteome Sciences PLC on Monday launched SysQuant SCP, a commercial service for single cell proteomics using isobaric labelling reagents.

Read more
25 Aug 2023 12:07

LONDON MARKET MIDDAY: FTSE 100 pushes higher ahead of Fed chair speech

(Alliance News) - The FTSE 100 edged higher at midday on Friday as all eyes turned to US Federal Reserve Chair Jerome Powell's address at Jackson Hole later in the day.

Read more
25 Aug 2023 10:26

AIM WINNERS & LOSERS: Panthera Resources secures litigation financing

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Friday.

Read more
25 Aug 2023 09:11

Proteome Sciences revenue, earnings dip in firist half

(Sharecast News) - Proteome Sciences released its unaudited financial results for the first six months of the year on Friday, reporting an increase in its proteomics services revenues to £1.01m, from £0.85m a year earlier.

Read more
25 Aug 2023 09:10

Proteome Sciences shares fall as swings to interim loss on costs

(Alliance News) - Proteome Sciences PLC on Friday reported higher costs in the first half of 2023 despite revenue remaining virtually flat, causing a swing to a loss.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.